PRF Technologies (PRFX) Cash from Operations (2020 - 2024)

PRF Technologies (PRFX) posted quarterly Cash from Operations of 3530000.0 for Q2 2024, up 276.24% year-on-year from 938241.77 in Q3 2023, and up 195.53% on a QoQ basis from 3695000.0 in Q1 2024.

PRF Technologies (PRFX) Cash from Operations (2020 - 2024) Analysis & Trends

PRF Technologies (PRFX) has reported Cash from Operations for 5 consecutive years, with 3530000.0 the latest figure, recorded in Q2 2024.

  • Quarterly Cash from Operations rose 276.24% year-over-year to 3530000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was 2889000.0 (up 62.55% YoY) and the FY2025 annual result came in at 3955000.0, up 68.66% from the prior year.
  • Cash from Operations improved to 3530000.0 in Q2 2024 per PRFX's latest filing, from 3695000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for PRFX reached as high as 4775447000.0 in Q4 2021 and fell as low as 4778576000.0 in Q3 2021.
  • A 5-year average of 1245166.67 and a median of 1571500.0 in 2022 frame the typical range for Cash from Operations.
  • The largest YoY upside for Cash from Operations was 236157.69% in 2021 against a maximum downside of 2181898.17% in 2021.
  • Year by year, Cash from Operations stood at 2023000.0 in 2020, then soared by 236157.69% to 4775447000.0 in 2021, then sank by 100.06% to 2868000.0 in 2022, then surged by 45.89% to 1552000.0 in 2023, then jumped by 327.45% to 3530000.0 in 2024.
  • According to Business Quant data, Cash from Operations over the past three periods registered 3530000.0, 3695000.0, and 1552000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -40.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 401.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 463.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 388.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 145.80 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.00 Mn
10 PRF Technologies 745,168.93 451,168.93 - -

Historic Data

Download Data
DateValue
Jun 30, 2024 3.53 Mn
Jun 30, 2024 3.53 Mn
Mar 31, 2024 -3.70 Mn
Mar 31, 2024 -3.70 Mn
Dec 31, 2023 -1.55 Mn
Dec 31, 2023 -1.55 Mn
Sep 30, 2023 -1.17 Mn
Sep 30, 2023 -1.17 Mn
Jun 30, 2023 -2.00 Mn
Jun 30, 2023 -2.00 Mn
Mar 31, 2023 -1.95 Mn
Mar 31, 2023 -1.95 Mn
Dec 31, 2022 -2.87 Mn
Dec 31, 2022 -2.87 Mn
Sep 30, 2022 -892,000.00
Sep 30, 2022 -892,000.00
Jun 30, 2022 -1.59 Mn
Jun 30, 2022 -1.59 Mn
Mar 31, 2022 -1.11 Mn
Mar 31, 2022 -1.11 Mn